ANCHOR LEAD: PARTICIPATION IN CLINICAL TRIALS FOR CANCER IS A GOOD IDEA, ELIZABETH TRACEY REPORTS
Only about 3% of people who might be eligible to participate in a clinical trial for new cancer treatments do so, national data reveal. But by not participating, folks with cancer may very well be depriving themselves of the best possible treatment, says Bill Nelson, director of the Kimmel Cancer Center at Johns Hopkins.
NELSON: I think people should use all their information conduits, whether it’s the Internet, these kind of health updates, to seek out what are the clinical trials available to them. As they learn about the clinical trials they’ll learn a lot about the disease, a lot about its treatment, and it’s a great educational opportunity, people are very interested when it’s a cancer diagnosis, what is my disease, what are my treatment options, how am I going to do, all of that comes in a clinical trial discussion, it’s a great way to pursue cancer care generally. :27
Nelson admits that most trials are found in urban areas or schools of medicine, but notes that participation may be possible through a community-based physician. At Johns Hopkins, I’m Elizabeth Tracey.